EUVIMEDDescubrir EUVIMED
Open access · CC BY-NC 4.0

Anogenital Contact Dermatitis in Spain: A REIDAC Study of Patients Undergoing Patch Testing in 2019–2024

Mercè Grau-Pérez iD, Pedro Mercader-García, Ana María Giménez-Arnau, Tatiana Sanz-Sánchez, Violeta Zaragoza Ninet, Susana Córdoba Guijarro, Francisco Javier Miquel Miquel, Juan Francisco Silvestre Salvador, Ricardo González-Pérez, Inmaculada Ruíz González, Esther Serra Baldrich, José Manuel Carrascosa and 18 more

Contact Dermatitis · 2026

DOI: 10.1111/cod.70048 ↗

At a glance

Journal article in Contact Dermatitis, 2026. Written by Mercè Grau-Pérez and 29 co-authors. Institution: Department of Dermatology, Hospital Universitario Puerta de Hierro Majadahonda, IDIPHISA, Madrid, Spain. Major MEDLINE topics: Dermatitis, Allergic Contact, Genital Diseases, Female, Genital Diseases, Male. Cited 1 times so far (Crossref); 45 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Agencia Española de Medicamentos y Productos Sanitarios, Fundación Piel Sana, Sanofi.

ResumenSubjectsDatos bibliográficosCiteRelated studies

Abstract (original language)

Background

The REIDAC (Spanish Registry for Research in Contact Dermatitis) conducts nationwide epidemiological surveillance of contact dermatitis in Spain. Anogenital involvement within REIDAC has not been previously studied.

Objectives

To describe the most common diagnoses and update relevant allergens in patients with anogenital lesions referred for patch testing.

Methods

We analysed patients who underwent patch testing within REIDAC from 2019 to 2024. Patients were classified into three groups: (G1) exclusively anogenital lesions, (G2) no anogenital involvement and (G3) both anogenital and non‐anogenital lesions. Sensitisation and relevance were assessed.

Results

Among 18 291 patients, 116 (0.6%) had exclusively anogenital lesions, 17 576 (96.1%) had no anogenital involvement and 599 (3.3%) had both. G1 patients were more likely to have at least one positive reaction (91.4%), a current relevant reaction (53.4%, diagnosed with allergic contact dermatitis, ACD) and to be polysensitised compared to other groups ( p < 0.001). 14.5% of anogenital ACD identified cases were not identified by the Spanish baseline series. Fragrances, preservatives, topical anaesthetics and steroids were the leading relevant allergens. Benzisothiazolinone, sodium metabisulfite and propolis emerged as new sensitisers.

Conclusion

ACD was highly prevalent among patients with anogenital lesions referred for patch testing. The threshold for patch testing in these patients may need reconsideration.

Subjects

MeSH terms (MEDLINE)

Dermatitis, Allergic ContactGenital Diseases, FemaleGenital Diseases, MaleHumansPatch TestsSpainFemaleMaleAdultMiddle AgedRegistriesAgedAllergensYoung AdultAdolescent

Author keywords

allergic contact dermatitisallergyanogenitaldermatologyenvironmental medicineepidemiologygenital diseases

Substances

Allergens

Authors and institutions

  • Department of Dermatology, Hospital Universitario Puerta de Hierro Majadahonda, IDIPHISA, Madrid, Spain.
  • Research Unit, Academia Española de Dermatología y Venereología (AEDV), Madrid, Spain.
  • Department of Dermatology, Hospital General Universitario José María Morales Meseguer, Murcia, Spain.
  • Department of Dermatology, Hospital del Mar Research Institute, Universitat Pompeu Fabra, Barcelona, Spain.
  • Department of Dermatology, Hospital Universitario Infanta Sofía, European University of Madrid, Madrid, Spain.
  • Department of Dermatology, Hospital General Universitario de Valencia, Valencia, Spain.

ORCID profiles: Mercè Grau-Pérez, Francisco José Navarro Triviño, Gemma Melé-Ninot, Fátima Tous Romero

Funding

  • Agencia Española de Medicamentos y Productos Sanitarios
  • Fundación Piel Sana
  • Sanofi
  • LEO Pharma
  • GlaxoSmithKline
  • Novartis

Cite

APA

Grau-Pérez, M., Mercader-García, P., Giménez-Arnau, A. M., Sanz-Sánchez, T., Ninet, V. Z., Guijarro, S. C., Miquel, F. J. M., Salvador, J. F. S., González-Pérez, R., González, I. R., Baldrich, E. S., Carrascosa, J. M., de Frutos, F. J. O., Serna, M. R., Ortega, M. E. G., Suárez, C. P., Triviño, F. J. N., Chicharro, P., Andreu, M., …, & Borrego, L. (2026). Anogenital Contact Dermatitis in Spain: A REIDAC Study of Patients Undergoing Patch Testing in 2019–2024. Contact Dermatitis. https://doi.org/10.1111/cod.70048

Vancouver

Grau-Pérez M, Mercader-García P, Giménez-Arnau AM, Sanz-Sánchez T, Ninet VZ, Guijarro SC, et al. Anogenital Contact Dermatitis in Spain: A REIDAC Study of Patients Undergoing Patch Testing in 2019–2024. Contact Dermatitis. 2026. doi:10.1111/cod.70048

BibTeX
@article{GrauPrez2026,
  author = {Grau-Pérez, Mercè and Mercader-García, Pedro and Giménez-Arnau, Ana María and Sanz-Sánchez, Tatiana and Ninet, Violeta Zaragoza and Guijarro, Susana Córdoba and Miquel, Francisco Javier Miquel and Salvador, Juan Francisco Silvestre and González-Pérez, Ricardo and González, Inmaculada Ruíz and Baldrich, Esther Serra and Carrascosa, José Manuel and de Frutos, Francisco Javier Ortiz and Serna, Mercedes Rodríguez and Ortega, María Elena Gatica and Suárez, Carmen Paredes and Triviño, Francisco José Navarro and Chicharro, Pablo and Andreu, Marta and Gilo, Araceli Sánchez and Pereyra Rodríguez, José Juan and Nieto, María Antonia Pastor and Melé-Ninot, Gemma and Guillén, Paloma Sánchez-Pedreño and de la Fuente, Enrique Gómez and Elosua-González, Marta and Munera-Campos, Mónica and Romero, Fátima Tous and Descalzo, Miguel Ángel and Borrego, Leopoldo},
  title = {Anogenital Contact Dermatitis in Spain: A REIDAC Study of Patients Undergoing Patch Testing in 2019–2024},
  journal = {Contact Dermatitis},
  year = {2026},
  doi = {10.1111/cod.70048}
}
Start for free →